The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...

The FDA accepted Novo Nordisk's NDA for an oral formulation of Wegovy. The agency is expected to release its verdict on the ...

The U.S. Food and Drug Administration has accepted Novo Nordisk's marketing application for an oral version of its ...

Hims & Hers launched a pharmacy-made weight-loss drug last year, taking advantage of an FDA rule allowing it to temporarily ...

CVS Health said it will significantly expand access to Novo Nordisk's blockbuster weight loss drug Wegovy for patients ...

Weight loss medications and bariatric surgery used to be considered last-resort options, but now, they’re everywhere. More ...

A new study analyzed how often people develop severe side effects after taking semaglutide — known by brand names Ozempic and ...

A decision is expected in the fourth quarter of 2025.

There are currently no drugs approved in the European Union to treat the liver condition known as MASH, but a new trial of ...

Weight loss pills either reduce appetite, boost metabolism or block fat absorption. Most people lose 5% to 10% of their body ...

Sometimes, it makes sense to skip insurance and instead take advantage of a health savings account or flexible savings ...

Effective July 1, 2025, CVS Caremark will place Wegovy injection 2.4 mg as preferred on its commercial template formularies.